Marc Casper, CEO of Thermo Fisher Scientific, discusses how the COVID-19 pandemic accelerated the global recognition of biotechnology's transformative potential. The crisis positioned American biotech companies at the forefront of innovation, demonstrating society's growing acceptance of scientific breakthroughs. Casper highlights how the pandemic served as a catalyst for advancing healthcare solutions and reshaping public perception of the industry's vital role in addressing global health challenges.

Summary auto-generated by AI from the original publisher's content. Editorial standards.